One pill can kill: Assessing the potential for fatal poisonings in children

Pediatric Annals

Volumn 34, Issue 12, 2005, Pages 964-968

  Matteucci, Michael J ^a,b  

^a UCSD MEDICAL CENTER   (United States)

^b US Army   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ADRENALIN; ANTIDOTE; ANTIMALARIAL AGENT; ATROPINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BICARBONATE; CAMPHOR; CHLOROQUINE; CLONIDINE; HYDROXYCHLOROQUINE; HYPERTENSIVE FACTOR; NAPHAZOLINE; OCTREOTIDE; OXYMETAZOLINE; SALICYLIC ACID METHYL ESTER; SULFONYLUREA DERIVATIVE; TETRYZOLINE;

ATTENTION DEFICIT DISORDER; BRADYCARDIA; CHILD; DRUG INTOXICATION; DRUG USE; EARLY DIAGNOSIS; GILLES DE LA TOURETTE SYNDROME; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; IRRITABILITY; PATIENT MONITORING; REVIEW; SEIZURE; SYMPTOM; WITHDRAWAL SYNDROME;

EID: 29144507725     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20051201-12     Document Type: Review

References (28)

1. Watson WA, Litovitz TL, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22(5):335-404.
2. Smith ER, Klein-Schwartz W. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers. J Emerg Med. 2005;28(4):437-443.
3. Jordan P, Brookes JG, Nikolic G, Le Couleur DG. Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol. 1999;37(7):861-864.
4. Don Michael TA, Aiwazzadeh S. The effects of acute chloroquine poisoning with special reference to the heart. Am Heart J. 1970;79(6):831-842.
5. Kelly JC, Wasserman GS, Bernard WD, Schultz C, Knapp J. Chloroquine poisoning in a child. Ann Emerg Med. 1990;19(1):47-50.
6. Clemessey JL, Favier C, Borron SW, et al. Hypokalemia related to acute chloroquine ingestion. Lancet. 1995;346(8979):877-880.
7. Tracy JW, Webster, Jr LT. Drugs used in the chemotherapy of protozoal infections: malaria. In: Hardman JG, Limbird LE, Oilman AG, eds. Goodman and Gilmans's Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:1069-1095.
8. Riou B, Barriot P, Rimailho A, Baud FJ. Treatment of severe chloroquine poisoning. N Engl J Med. 1988;318(1):1-6.
9. Love JN, Sammon M, Smereck J. Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med. 2004;27(1):49-54.
10. Liebert EL, Shannon MW. Small doses, big problems: a selected review of highly toxic common medications. Pediatr Emerg Care. 1993;9(5):292-297.
11. Kopelman R, Miller S, Kelly R, Sunshine I. Camphor intoxication treated with lipid hemodialysis. JAMA. 1979;241(7):727-728.
12. Klein-Schwatz W. Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Adolesc Med. 2002;156(4):392-396.
13. Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. Vet Human Toxicol. 2003;45(4):210-212.
14. Caravati EM, Bennett DL. Clonidine transdermal patch poisoning. Ann Emerg Med. 1988;17(2):175-176.
15. Hoffman BB. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilmans's Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:233-234.
16. Eddy O, Howell JM. Are one or two dangerous? Clonidine and topical imidazoline exposure in toddlers. J Emerg Med. 2003;25(3):297-302.
17. Spiller HA, Klein-Schwartz W, Colvin JM, et al. Toxic clonidine ingestion in children. J Pediair. 2005;146(2):263-266.
18. Flomenbaum NE. Salicylates. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al., eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York, NY: McGraw-Hill; 2002:507-518.
19. Wolowich WR, Hadley CM, Kelley MT. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen. J Toxicol Clin Toxicol. 2003;41(4):355-358.
20. Yip L, Dart RC, Gabow PA. Concepts and controversies in salicylate toxicity. Emerg Med Clin. 1994;12(2):351-364.
21. Yip L. Salicylates. In: Dart RC, ed. Medical Toxicology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:739-749.
22. Litovitz TL, Klein-Schwartz W, Dyer KS, et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998;16(5):443-497.
23. Spiller HA, Villalobos D, Krenzelok EP, et al. Prospective multicenter study of sulfonylurea ingestion in children. J Pediair. 1997;131(1 Pt 1):141-146.
24. Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilmans's Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill: 2001:1679-1714.
25. Quadrani DA, Spiller HA, Widder P. Five-year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol. 1996;34(3):267-270.
26. Burkhart KK. When does hypoglycemia develop after sulfonylurea ingestion? Ann Emerg Med. 1998;31(6):771-772.
27. Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med. 1998; 31(6):773-776.
28. Little GL, Boniface KS. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med. 2005;28(3):305-310.